⌘K

Login Start Free

Home/Filings/4/0001842952-25-000010

4//SEC Filing

Pasternak Andy 4

Accession 0001842952-25-000010

CIK 0001842952other

View on SEC.gov Company Profile

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 8:43 PM ET

Size

5.5 KB

Accession

0001842952-25-000010

Insider Transaction Report

Form 4

Period: 2025-01-13

Context Therapeutics Inc.CNTX

Director

Transactions

Award
Stock Option (right to buy)
2025-01-13+20,685→ 20,685 total
Exercise: $1.03Exp: 2035-01-12→ Common Stock (20,685 underlying)

Footnotes (1)

[F1]The option vests and becomes exercisable on the earlier of (i) June 13, 2025 or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer.

Documents

1 file

4
wk-form4_1736905424.xmlPrimary
FORM 4

Issuer

Context Therapeutics Inc.

CIK 0001842952

Entity typeother

Related Parties

1

filerCIK 0001792746

Filing Metadata

Form type: 4
Filed: Jan 13, 7:00 PM ET
Accepted: Jan 14, 8:43 PM ET
Size: 5.5 KB

View on SEC.gov